More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

That’s where personalized weight loss programs come in. They tailor recommendations to your unique needs, whether it’s ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

Compounded copycat drugs containing tirzepatide, many sold by online pharmacies, will no longer be allowed. Semaglutide, the main ingredient in Ozempic and Wegovy, is in ongoing shortage ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...